8-K
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENTREPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 24, 2020
Kewaunee Scientific Corporation
(Exact name of registrant as specified in its charter)
| Delaware | 0-5286 | 38-0715562 |
|---|---|---|
| (State or other jurisdictionof incorporation) | (CommissionFile Number) | (I.R.S. EmployerIdentification No.) |
| 2700 West Front Street<br><br><br>Statesville, North Carolina | 28677 | |
| --- | --- | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephonenumber, including area code: 704-873-7202
N/A
(Former name orformer address, if changed since last report.)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchangeon which registered |
|---|---|---|
| Common Stock, $2.50 par value | KEQU | NASDAQ Global Market |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17<br>CFR 240.14a-12) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| --- | --- |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 8.01 | Other Events |
|---|
On March 24, 2020, in response to the COVID-19 pandemic, Prime Minister Narendra Modi of India announced a “complete” nationwide lockdown, effective at midnight local time and continuing for a period of at least 21 days. In response to Prime Minister Modi’s announcement and other recent orders of the Government of Karnataka, India, Kewaunee Scientific Corporation (“Kewaunee”) has temporarily suspended operations at its Bangalore, India manufacturing facility. It is unknown how long this lockdown will continue as the situation around COVID-19 continues to evolve. Kewaunee plans to file a Current Report on Form 8-K to notify the public once operations at its Bangalore, India manufacturing facility have resumed.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| (Registrant) | ||
|---|---|---|
| Kewaunee Scientific Corporation | ||
| Date: March 24, 2020 | /s/ Donald T. Gardner III | |
| Donald T. Gardner III | ||
| Vice President, Finance and Chief Financial Officer |